Efficacy, safety, and multi-omics analysis of pembrolizumab combined with nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: A single-arm phase 2 study
帕博利珠单抗联合白蛋白紫杉醇和铂类药物一线治疗复发或转移性头颈部鳞状细胞癌患者的疗效、安全性和多组学分析:一项单臂 II 期研究
期刊:Chinese Journal of Cancer Research
影响因子:6.3
doi:10.21147/j.issn.1000-9604.2024.06.09
Gui, Lin; Chen, Xinrui; Zhang, Wen; Xie, Zucheng; Zhang, Yu; Li, Weihua; Xie, Tongji; Yao, Jiarui; Zhu, Haohua; Tang, Le; Yang, Jianliang; Liu, Peng; Qin, Yan; Zhang, Changgong; He, Xiaohui; Shi, Yuankai